stars 1 stars 2 stars 3

SOLID Drug Development SA (SDD) is a strategic and operational consultancy for the development of biotech and pharmaceutical products. Operating from Geneva, Switzerland, SDD undertakes the entire process of drug development – from laboratory to market. SDD'a approach substantially increases the value of a project by expertly facilitating its movement from the lab to its animal and then clinical proof of concept. This allows the drug sponsor to invest in that particular project per se instead of spending money in building dedicated internal teams or infrastructures. Such an approach greatly reduces costs and operational problems for young but also large pharmaceutical companies. Solid Drug Development's expertise ranges across CMC, including technology transfers, non-clinical, clinical, regulatory and strategic concerns.

Solid Drug Development Questions

The Solid Drug Development annual revenue was $1 million in 2026.

Jean-Marc Combette is the CEO of Solid Drug Development.

4 people are employed at Solid Drug Development.

Solid Drug Development is based in Geneva, Geneva.

The NAICS codes for Solid Drug Development are [32, 3254, 32541, 325].

The SIC codes for Solid Drug Development are [28, 283].

Top Solid Drug Development Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users